Terms: = Kidney tumors AND POU5F1, MGC22487, 5460, ENSG00000230336, POU5F1P1, OTF3P1, Oct4, OCT4, OCT3, OTF3C, OTF4, OTF3 AND Diagnosis
7 results:
1. EMX2OS targeting IGF2BP1 represses Wilms' tumour stemness,epithelial-mesenchymal transition and metastasis.
Zhang HM; Cui MY; Chen ZH
J Genet; 2023; 102():. PubMed ID: 36722215
[TBL] [Abstract] [Full Text] [Related]
2. Primary renal sarcoma with SS18::pou5f1 gene fusion.
Argani P; Matoso A; Gross JM; Zhang Y; SoRelle JA; Gagan J; Antonescu CR; Palsgrove D
Genes Chromosomes Cancer; 2022 Sep; 61(9):572-577. PubMed ID: 35521683
[TBL] [Abstract] [Full Text] [Related]
3. Ancillary studies in fine needle aspiration of the kidney.
Renshaw AA; Gould EW
Cancer Cytopathol; 2018 Aug; 126 Suppl 8():711-723. PubMed ID: 30156770
[TBL] [Abstract] [Full Text] [Related]
4. Renal Cell Carcinoma, Unclassified with Medullary Phenotype and Synchronous Renal Clear Cell Carcinoma Present in a Patient with No Sickle Cell Trait/Disease: Diagnostic and Therapeutic Challenges.
Lai JZ; Lai HH; Cao D
Anticancer Res; 2018 Jun; 38(6):3757-3761. PubMed ID: 29848739
[TBL] [Abstract] [Full Text] [Related]
5. Uncommon Localization of Extrarenal Xp11.2 Translocation-associated Renal Cell Carcinoma (RCC): Case Report.
Al-Maghrabi JA; Khabaz MN
Appl Immunohistochem Mol Morphol; 2020 Apr; 28(4):e33-e35. PubMed ID: 28877071
[TBL] [Abstract] [Full Text] [Related]
6. Newly available antibodies with practical applications in surgical pathology.
Chan JK
Int J Surg Pathol; 2013 Dec; 21(6):553-72. PubMed ID: 24225578
[TBL] [Abstract] [Full Text] [Related]
7. Establishing a germ cell origin for metastatic tumors using oct4 immunohistochemistry.
Cheng L
Cancer; 2004 Nov; 101(9):2006-10. PubMed ID: 15386301
[TBL] [Abstract] [Full Text] [Related]
